Danimer Scientific, Inc.
DNMR
$1.13
-$0.165-12.74%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 37.43M | 39.75M | 44.98M | 46.68M | 51.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.43M | 39.75M | 44.98M | 46.68M | 51.06M |
| Cost of Revenue | 61.35M | 64.17M | 69.16M | 71.00M | 71.80M |
| Gross Profit | -23.92M | -24.43M | -24.17M | -24.32M | -20.74M |
| SG&A Expenses | 41.33M | 51.16M | 61.05M | 72.54M | 74.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 124.30M | 139.04M | 156.63M | 171.87M | 175.14M |
| Operating Income | -86.87M | -99.29M | -111.65M | -125.19M | -124.07M |
| Income Before Tax | -111.19M | -129.04M | -145.69M | -155.15M | -143.82M |
| Income Tax Expenses | 8.00K | 474.00K | 411.00K | 319.00K | 274.00K |
| Earnings from Continuing Operations | -111.20 | -129.52 | -146.10 | -155.47 | -144.09 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -111.20M | -129.52M | -146.10M | -155.47M | -144.09M |
| EBIT | -86.87M | -99.29M | -111.65M | -125.19M | -124.07M |
| EBITDA | -57.16M | -69.70M | -82.32M | -95.81M | -94.79M |
| EPS Basic | -41.01 | -49.46 | -57.07 | -60.97 | -56.59 |
| Normalized Basic EPS | -26.87 | -30.61 | -35.48 | -37.90 | -35.22 |
| EPS Diluted | -41.01 | -49.46 | -57.07 | -60.97 | -56.59 |
| Normalized Diluted EPS | -26.87 | -30.61 | -35.48 | -37.90 | -35.22 |
| Average Basic Shares Outstanding | 11.06M | 10.62M | 10.25M | 10.20M | 10.18M |
| Average Diluted Shares Outstanding | 11.06M | 10.62M | 10.25M | 10.20M | 10.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
